Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
National Cancer Institute (NCI)
AIDS Malignancy Consortium
Jonsson Comprehensive Cancer Center
AIDS Malignancy Consortium
AIDS Malignancy Consortium